Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 15, 2006 (Vol. 26, No. 8)

Market Increases Oligonucleotide Demands

Driven by Promise of miRNA and siRNA for Therapeutic and Research Applications

  • Even as new players join the competitive market for research- and pharmaceutical-grade oligonucleotides, acquisitions and partnerships continue to change the face of the supplier landscape. Demand is driven by the established market for primers and probes and the growing market for RNAs for research and therapeutic applications. With immunostimulatory ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.